While orforglipron succeeded in a Phase 3 trial, its weight loss effects were more modest than investors and analysts ...

In the mirror photo, Depp, 26, wore a sheer black minidress draped over a matching white lace bra and underwear set, with her ...

Shares of global pharmaceutical company Eli Lilly (NYSE:LLY) fell 13.9% in the afternoon session after its oral weight-loss ...

Eli Lilly's growth is fueled by GLP-1 blockbusters and a solid pipeline, yet high valuations and reliance on key drugs ...

Eli Lilly & Co.’s experimental pill helped patients shed roughly 11% of their body weight, about 25 pounds, in a late-stage ...

A transformative moment in the global fight against obesity has emerged with the announcement of positive topline results ...

A new daily weight loss pill could be available soon – and a recent trial has shown that people taking the drug can shed ...

Quantum sensors can be used in medical technologies, navigation systems, and more, but they're too expensive for most people.

Eli Lilly said on Tuesday its drug for a type of blood cancer was more effective in a head-to-head study against AbbVie's ...

In the first Phase 3 trial of its once-daily oral GLP-1 pill in people with obesity, drugmaker Eli Lilly said Thursday that ...

Eli Lilly ( LLY 0.14%) has been one of the best-performing pharmaceutical leaders in the past five years. Thanks to strong ...

A creditor is claiming at least $8.6 million damages in alleging racketeering and wire fraud by companies, colleges and ...